FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:3235-0104
Expires:02/28/2011
Estimated average burden
hours per response0.5

1. Name and Address of Reporting Person *

Squarepoint Ops LLC

2. Date of Event Requiring Statement (Month/Day/Year)

06/28/2024

3. Issuer Name and Ticker or Trading Symbol

Cano Health, Inc. [CANOQ]
(Last)
(First)
(Middle)


250 WEST 55TH STREET, 32ND FLOOR

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

NEW YORK, NY 10019
(City)
(State)
(Zip)

6. Individual or Joint/Group Filing

(Check applicable line)

__X__ Form Filed by One Reporting Person
_____ Form Filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)

2. Amount of Securities Beneficially Owned (Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

4. Nature of Indirect Beneficial Ownership (Instr. 5)

Common Stock

7,415,060 (1) (2)
I

Arini Credit Master Fund Limited (3)

Common Stock

728,962 (1) (4)
I

Squarepoint Diversified Partners Fund 7 Limited (5)

Common Stock

16,997 (1) (6)
I

Squarepoint Master Fund Limited (7)



Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)

2. Date Exercisable and Expiration Date (Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)

6. Nature of Indirect Beneficial Ownership (Instr. 5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrant (Right to Buy)

06/28/202906/28/2029

Common Stock

665,606 (1) (2) $23.5I

Arini Credit Master Fund Limited (3)

Warrant (Right to Buy)

06/28/202906/28/2029

Common Stock

72,682 (1) (4) $23.5I

Squarepoint Diversified Partners Fund 7 Limited (5)




Explanation of Responses:

Pursuant to the Issuer's Modified Fourth Amended Joint Chapter 11 Plan of Reorganization (the "Plan"), which was confirmed by the United States Bankruptcy Court for the District of Delaware on June 28, 2024 and became effective on June 28, 2024 (the "Effective Date"), each share of the Issuer's Class A Common Stock, $0.01 par value per share (the "Old Common Stock") and warrants to purchase Old Common Stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value. In addition, on the Effective Date, pursuant to the Plan and in connection with the Issuer's emergence from bankruptcy, the Issuer (i) newly issued 41,800,000 shares of common stock, $0.0001 par value per share (the "Common Stock") and (ii) was authorized to issue an aggregate of up to 2,200,150 warrants, each exercisable for one share of Common Stock, at an initial exercise price of $25.30 per share, exercisable for a 5-year period commencing on the Effective Date (the "Warrants").

Pursuant to the Plan, Arini Credit Master Fund Limited ("Arini"), as a holder of First Lien Claims (as defined in the Plan), received an aggregate of 7,415,060 shares of Common Stock, and as a holder of RSA GUC Claims (as defined in the Plan), received an aggregate of 665,606 Warrants, in connection with the equitization of allowable Claims (as defined the Plan).

Arini directly holds 7,415,060 shares of Common Stock and 665,606 Warrants. Squarepoint Ops LLC ("Squarepoint Ops") is the investment advisor to Arini and has the ability to indirectly control the decisions of Arini regarding the vote and disposition of securities held by Arini and as such may be deemed to have an indirect beneficial ownership of the securities held of record by Arini. Squarepoint Ops disclaims beneficial ownership of such securities directly held by Arini except to the extent of its pecuniary interest therein.

Pursuant to the Plan, Squarepoint Diversified Partners Fund 7 Limited ("Squarepoint Fund 7"), as a holder of First Lien Claims (as defined in the Plan), received an aggregate of 728,962 shares of Common Stock, and as a holder of RSA GUC Claims (as defined in the Plan), received an aggregate of 72,682 Warrants in connection with the equitization of allowable Claims (as defined the Plan).

Squarepoint Fund 7 directly holds the 728,962 shares of Common Stock and 72,682 Warrants. Squarepoint Ops is the investment advisor to Squarepoint Fund 7 and has the ability to indirectly control the decisions of Squarepoint Fund 7 regarding the vote and disposition of securities held by Squarepoint Fund 7 and as such may be deemed to have an indirect beneficial ownership of the securities held of record by Squarepoint Fund 7. Squarepoint Ops disclaims beneficial ownership of such securities directly held by Squarepoint Fund 7 except to the extent of its pecuniary interest therein.

Pursuant to the Plan, Squarepoint Master Fund Limited ("Squarepoint Master Fund"), as a holder of First Lien Claims (as defined in the Plan), received an aggregate of 16,997 shares of Common Stock in connection with the equitization of allowable Claims (as defined the Plan).

Squarepoint Master Fund directly holds the 16,997 shares of Common Stock. Squarepoint Ops is the investment advisor to Squarepoint Master Fund and has the ability to indirectly control the decisions of Squarepoint Master Fund regarding the vote and disposition of securities held by Squarepoint Master Fund and as such may be deemed to have an indirect beneficial ownership of the securities held of record by Squarepoint Master Fund. Squarepoint Ops disclaims beneficial ownership of such securities directly held by Squarepoint Master Fund except to the extent of its pecuniary interest therein.

Remarks:

Ex. 24.1 - Power of Attorney



Signatures

/s/ Ronald Veith, Attorney-in-Fact for Squarepoint Ops LLC

07/08/2024
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

 

Exhibit 24.1

POWER OF ATTORNEY

KNOW ALL PEOPLE BY THESE PRESENTS, that each person whose signature appears below hereby makes, constitutes and appoints Ronald Veith with full power to act without the other, as his or her agent and attorney-in-fact for the purpose of executing in his or her name, in his or her capacity as a Trustee and/or officer of Squarepoint Ops LLC, any statement of beneficial ownership on Form 3, 4, or 5 to be filed with the United States Securities and Exchange Commission.

All past acts of an attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.

This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original, but which taken together shall constitute one instrument.

This Power of Attorney shall be valid from the date hereof until revoked by me.

IN WITNESS HEREOF I have executed this instrument as of the 8th day of July, 2024.

/s/ Brad Kurtzman

Manager

Brad Kurtzman

/s/ Benjamin Servenay

Manager

Benjamin Servenay

/s/ Ronald Veith

Manager

Ronald Veith